Linezolid plus standard care for staph bloodstream infections
Treatments studied
Part of Infections clinical trials.
This trial tests whether adding linezolid, an antibiotic that stops bacteria from making proteins, to usual care works better for treating Staphylococcus aureus bloodstream infections. You may be eligible if you have this infection and are hospitalized.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a Staphylococcus aureus (staph) infection confirmed in a blood test
- You are currently in the hospital at a participating center
- You are 18 years or older
- You can give written consent, or a doctor can include you under emergency consent rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two antibiotics, cloxacillin and benzylpenicillin, to see which works better for patients with a bloodstream infection caused by a specific type of staph bacteria that responds well to penicillin. It may help guide more effective treatment.
This Phase 2 study tests whether continuous IV antibiotics plus “drug level monitoring” (TDM) works better than the usual treatment for complicated Staph aureus infections. It may help ensure the antibiotic dose stays in an effective range while you’re being treated.
This trial looks at how well certain penicillin-type antibiotics work for treating a bloodstream infection caused by a bacterium called Enterococcus faecalis. It may help doctors know which treatment is best for patients with this infection.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
This trial tests whether giving two antibiotics early, instead of the usual one, improves recovery for people with a staph bloodstream infection (a serious bacterial infection in the blood). If you qualify, participation will involve close monitoring and follow-up care.
This trial tests whether adding clopidogrel, a blood thinner, to standard care can help treat staph bloodstream infections. It may reduce the risk of complications, but it is only for patients who can take oral medications and are not at high risk of bleeding.
Hear when a new Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.